Underwriting Agreements in the Pharmaceuticals Industry

875 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (5 contracts)
Accelerated Pharma, Inc. (3)
ACELRX PHARMACEUTICALS INC (3)
Acer Therapeutics Inc. (6)
ACHILLION PHARMACEUTICALS INC (5)
Aclaris Therapeutics, Inc. (6)
Adamis Pharmaceuticals Corp (6)
ADIAL PHARMACEUTICALS, INC. (7)
Aegerion Pharmaceuticals, Inc. (4)
AEON Biopharma, Inc. (1)
AERIE PHARMACEUTICALS INC (3)
Aerpio Pharmaceuticals, Inc. (1)
AGILE THERAPEUTICS INC (6)
Akers Biosciences, Inc. (4)
ALDER BIOPHARMACEUTICALS INC (7)
Alexza Pharmaceuticals Inc. (1)
ALGORX PHARMACEUTICALS INC (2)
ALIMERA SCIENCES INC (1)
Allergan, plc (3)
Amag Pharmaceuticals (6)
Amphastar Pharma (1)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (4)
Amylyx Pharmaceuticals, Inc. (2)
AN2 Therapeutics, Inc. (2)
Anacor Pharmaceuticals, Inc. (3)
ANADYS PHARMACEUTICALS INC (1)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (2)
ANI Pharma Inc (5)
Anthera Pharmaceuticals Inc (3)
APRICUS BIOSCIENCES, INC. (10)
Aquestive Therapeutics, Inc. (3)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (5)
ARTELO BIOSCIENCES, INC. (3)
ARVINAS, INC. (3)
Assertio Therapeutics, Inc (2)
ATAI Life Sciences B.V. (1)
Atea Pharmaceuticals, Inc. (1)
Athira Pharma, Inc. (2)
AUXILIUM PHARMACEUTICALS INC (1)
AVADEL PHARMACEUTICALS PLC (2)
AVALON PHARMACEUTICALS INC (1)
AVANIR PHARMACEUTICALS, INC. (2)
AVENUE THERAPEUTICS, INC. (6)
Axsome Therapeutics, Inc. (4)
AYTU BIOSCIENCE, INC (10)
Baudax Bio, Inc. (2)
Bausch Health Companies Inc. (2)
Big Rock Partners Acquisition Corp. (4)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
Biofrontera Inc. (3)
Biohaven Ltd. (2)
BioPharmX Corp (8)
Blue Water Acquisition Corp. (7)
Braeburn Pharmaceuticals, Inc. (1)
Bright Green Corp (1)
Bristol-Myers Squibb (9)
CADENCE PHARMACEUTICALS INC (2)
Canbiola, Inc. (2)
Cancer Prevention Pharmaceuticals, Inc. (2)
Cara Therapeutics, Inc. (5)
CASSAVA SCIENCES INC (2)
Catalent Inc (9)
Celator Pharmaceuticals Inc (2)
CELGENE CORP (6)
Cerecor Inc. (7)
CHIASMA, INC (4)
CinCor Pharma, Inc. (2)
Cingulate Inc. (4)
Citius Pharmaceuticals, Inc. (7)
Clearside Biomedical, Inc. (3)
CNS Pharmaceuticals, Inc. (4)
Cocrystal Pharma, Inc. (4)
COGNITION THERAPEUTICS INC (4)
COLLEGIUM PHARMACEUTICAL, INC (4)
Context Therapeutics Inc. (1)
ContraVir Pharmaceuticals, Inc. (6)
Corcept Therapeutics Incorporated (3)
CorMedix Inc. (3)
CUBIST PHARMACEUTICALS INC (2)
CUMBERLAND PHARMACEUTICALS INC (1)
CymaBay Therapeutics, Inc. (9)
Cyteir Therapeutics, Inc. (1)
Dermata Therapeutics, Inc. (2)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (2)
DURECT CORP (4)
Edgewise Therapeutics, Inc. (3)
Egalet Corp (3)
Elanco Animal Health Inc (4)
Eleison Pharmaceuticals Inc (1)
Elixir Pharmaceuticals, Inc. (1)
Eloxx Pharmaceuticals, Inc. (4)
Endo International plc (1)
Endo Pharmaceuticals Solutions Inc. (1)
Eton Pharmaceuticals, Inc. (4)
Evofem Biosciences, Inc. (6)
Evoke Pharma Inc (7)
Evolus, Inc. (7)
EYEGATE PHARMACEUTICALS INC (11)
EYENOVIA, INC. (6)
EyePoint Pharmaceuticals, Inc. (7)
EYETECH PHARMACEUTICALS INC (1)
Foamix Pharmaceuticals Ltd. (1)
Fulcrum Therapeutics, Inc. (5)
GRAYBUG VISION, INC. (1)
GUILFORD PHARMACEUTICALS INC (1)
GW PHARMACEUTICALS PLC (1)
Harmony Biosciences Holdings, Inc. (1)
HARROW HEALTH, INC. (8)
Haymaker Acquisition Corp. III (4)
Horizon Pharma plc (7)
Hoth Therapeutics, Inc. (5)
IDENIX PHARMACEUTICALS INC (4)
Ikena Oncology, Inc. (2)
IMARA Inc. (2)
INNOVATE BIOPHARMACEUTICALS, INC. (3)
Innoviva, Inc. (1)
Intersect ENT, Inc. (3)
Intra-Cellular Therapies, Inc. (8)
Iterum Therapeutics plc (2)
Jaguar Health, Inc. (7)
Jazz Pharmaceuticals plc (3)
Johnson & Johnson (3)
Journey Medical Corp (2)
Kala Pharmaceuticals, Inc. (3)
Kaleido Biosciences, Inc. (3)
KEMPHARM, INC (4)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (2)
Level Brands, Inc. (7)
Lexaria Bioscience Corp. (3)
Lilly (Eli) & Co. (14)
LIPELLA PHARMACEUTICALS INC (3)
Lipocine Inc. (3)
Liquidia Corp (2)
Liquidia Technologies Inc (3)
Longboard Pharmaceuticals, Inc. (3)
Lyra Therapeutics, Inc. (1)
MAP Pharmaceuticals, Inc. (2)
MARINUS PHARMACEUTICALS INC (8)
Menlo Therapeutics Inc. (2)
Merck (3)
Milestone Pharmaceuticals Inc. (3)
Mind Medicine (MindMed) Inc. (2)
MIRA PHARMACEUTICALS, INC. (2)
Molecular Insight Pharmaceuticals, Inc. (1)
Mylan N.V. (1)
MYnd Analytics, Inc. (4)
MyoKardia Inc (6)
Nabriva Therapeutics plc (2)
NEKTAR THERAPEUTICS (2)
Neos Therapeutics, Inc. (4)
Neuralstem, Inc. (8)
NEW RIVER PHARMACEUTICALS INC (1)
NGM BIOPHARMACEUTICALS INC (2)
NovaBay Pharmaceuticals, Inc. (3)
Novan, Inc. (4)
NPS PHARMACEUTICALS INC (4)
OCULAR THERAPEUTIX, INC (8)
Odonate Therapeutics, Inc. (3)
OMEROS CORP (8)
Omthera Pharmaceuticals, Inc. (1)
OncoMed Pharmaceuticals Inc (1)
Onconova Therapeutics, Inc. (10)
ONYX PHARMACEUTICALS INC (3)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (2)
OptiNose, Inc. (6)
ORAMED PHARMACEUTICALS INC. (1)
Osmotica Pharmaceuticals plc (3)
OTONOMY, INC. (5)
Pacira Pharmaceuticals, Inc. (4)
Panacea Acquisition Corp (2)
Paratek Pharmaceuticals, Inc. (4)
PaxMedica, Inc. (4)
Perrigo (3)
Pfizer (8)
Phathom Pharmaceuticals, Inc. (3)
Phibro Animal Health Corporation (1)
Planet 13 Holdings Inc. (1)
PLIANT THERAPEUTICS, INC. (3)
PLx Pharma Inc. (7)
PONIARD PHARMACEUTICALS, INC. (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (1)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (1)
PROVECTUS BIOPHARMACEUTICALS, INC. (1)
Provention Bio, Inc. (5)
Pulmatrix, Inc. (8)
QUATRX PHARMACEUTICALS CO (1)
Ra Pharmaceuticals, Inc. (3)
Rain Therapeutics Inc. (3)
Rani Therapeutics Holdings, Inc. (1)
REATA PHARMACEUTICALS INC (6)
Recro Pharma, Inc. (5)
RELMADA THERAPEUTICS, INC. (2)
resTORbio, Inc. (5)
Revance Therapeutics, Inc. (8)
Rib-X Pharmaceuticals, Inc. (1)
Roivant Sciences Ltd. (2)
Royalty Pharma plc (3)
Sagent Pharmaceuticals, Inc. (2)
SALIX PHARMACEUTICALS LTD (1)
SANCILIO PHARMACEUTICALS COMPANY, INC. (1)
Satsuma Pharmaceuticals, Inc. (1)
Scopus BioPharma Inc. (1)
scPharmaceuticals Inc. (3)
SCYNEXIS INC (6)
SenesTech, Inc. (5)
Sienna Biopharmaceuticals, Inc. (2)
Sonoma Pharmaceuticals, Inc. (6)
Strongbridge Biopharma plc (2)
Sucampo Pharmaceuticals, Inc. (2)
Supernus Pharmaceuticals, Inc. (2)
SYNERGY PHARMACEUTICALS, INC. (5)
Tarsus Pharmaceuticals, Inc. (4)
Telomir Pharmaceuticals, Inc. (2)
Tenzing Acquisition Corp. (5)
Terns Pharmaceuticals, Inc. (3)
TETRALOGIC PHARMACEUTICALS CORP (1)
TETRAPHASE PHARMACEUTICALS INC (5)
TEVA PHARMACEUTICAL INDUSTRIES LTD (2)
TFF Pharmaceuticals, Inc. (4)
The Medicines Company (2)
TherapeuticsMD, Inc. (12)
Theravance Biopharma, Inc. (5)
Theseus Pharmaceuticals, Inc. (1)
Tilray, Inc. (4)
TITAN PHARMACEUTICALS INC (8)
Trevi Therapeutics, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (1)
Tricida, Inc. (2)
Trulieve Cannabis Corp. (1)
Urovant Sciences Ltd. (1)
Valera Pharmaceuticals Inc (1)
Vallon Pharmaceuticals, Inc. (2)
Ventyx Biosciences, Inc. (1)
Verona Pharma plc (1)
Verrica Pharmaceuticals Inc. (4)
VIA Pharmaceuticals, Inc. (1)
Viamet Pharmaceuticals Holdings LLC (1)
VICURON PHARMACEUTICALS INC (1)
Virpax Pharmaceuticals, Inc. (2)
Vitae Pharmaceuticals, Inc (3)
VIVUS INC (3)
Wave Life Sciences Ltd. (6)
XERIS PHARMACEUTICALS INC (3)
Zoetis (6)
ZOGENIX, INC. (7)
Zomedica Pharmaceuticals Corp. (2)
Zynerba Pharmaceuticals, Inc. (3)

Recent Contracts

Underwriting Agreement, dated April 18, 2024, by and between NRx Pharmaceuticals, Inc. and EF Hutton LLC (Big Rock Partners Acquisition Corp., Filed With SEC on April 19, 2024)
Underwriting Agreement, dated April 17, 2024, by and among the Company, J.P. Morgan Securities LLC, Leerink Partners LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and RBC... (Intra-Cellular Therapies, Inc., Filed With SEC on April 18, 2024)
Underwriting Agreement, dated March 19, 2024, by and among Aquestive Therapeutics, Inc. and Leerink Partners LLC and Piper Sandler & Co., as representatives of the several... (Aquestive Therapeutics, Inc., Filed With SEC on March 21, 2024)
Underwriting Agreement, dated March 11, 2024, by and between Evolus, Inc. and Leerink Partners, LLC and Stifel, Nicolaus & Company, Incorporated (Evolus, Inc., Filed With SEC on March 13, 2024)
Underwriting Agreement, dated as of March 11, 2024, by and between Cognition Therapeutics, Inc. and Titan Partners Group LLC, as representative of the underwriters (COGNITION THERAPEUTICS INC, Filed With SEC on March 13, 2024)
Underwriting Agreement, dated March 7, 2024, by and between Mind Medicine (MindMed) Inc. and Leerink Partners LLC and Cantor Fitzgerald & Co (Mind Medicine (MindMed) Inc., Filed With SEC on March 11, 2024)
Underwriting Agreement, dated March 5, 2024, by and between Planet 13 Holdings Inc. and Canaccord Genuity LLC, as representative of the several underwriters listed in Schedule A... (Planet 13 Holdings Inc., Filed With SEC on March 7, 2024)
Underwriting Agreement, dated March 4, 2024, by and between the Company and the Underwriter (Revance Therapeutics, Inc., Filed With SEC on March 5, 2024)
Underwriting Agreement, dated February 28, 2024, by and between the Company and Piper Sandler & Co (Milestone Pharmaceuticals Inc., Filed With SEC on March 4, 2024)
Underwriting Agreement, dated February 29, 2024, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC (Tarsus Pharmaceuticals, Inc., Filed With SEC on March 1, 2024)
Underwriting Agreement, dated February 27, 2024, by and between NRx Pharmaceuticals, Inc. and EF Hutton LLC (Big Rock Partners Acquisition Corp., Filed With SEC on February 28, 2024)
Underwriting Agreement, dated February 14, 2024, among Bristol-Myers Squibb Company and the underwriters named therein (Bristol-Myers Squibb, Filed With SEC on February 22, 2024)
Underwriting Agreement, dated as of February 8, 2024, by and among the Company, Kingswood Investments, division of Kingswood Capital Partners, LLC and the other underwriters named... (Telomir Pharmaceuticals, Inc., Filed With SEC on February 13, 2024)
Underwriting Agreement, dated February 7, 2024, among Eli Lilly and Company and BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank... (Lilly (Eli) & Co., Filed With SEC on February 9, 2024)
Underwriting Agreement, dated February 8, 2024, by and among Evoke Pharma, Inc., Craig-Hallum Capital Group LLC and Laidlaw & Company (UK) Ltd (Evoke Pharma Inc, Filed With SEC on February 9, 2024)
Underwriting Agreement dated as of January 29, 2024, by and between the Company and WallachBeth Capital LLC (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on February 2, 2024)
Underwriting Agreement, dated as of January 22, 2024, by and among the Company and Jefferies LLC and Guggenheim Securities, LLC, as representatives of the several underwriters... (resTORbio, Inc., Filed With SEC on January 24, 2024)
Form of Underwriting Agreement (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on January 22, 2024)
Underwriting Agreement between the Company and Leerink Partners LLC, dated as of January 19, 2024 (Edgewise Therapeutics, Inc., Filed With SEC on January 19, 2024)
Underwriting Agreement (Evoke Pharma Inc, Filed With SEC on January 11, 2024)
Underwriting Agreement by and among the Company, Cantor Fitzgerald & Co. and Citigroup Global Markets Inc. dated January 3, 2024 (Longboard Pharmaceuticals, Inc., Filed With SEC on January 4, 2024)
Form of Underwriting Agreement (Telomir Pharmaceuticals, Inc., Filed With SEC on December 19, 2023)
Underwriting Agreement (Evoke Pharma Inc, Filed With SEC on December 15, 2023)
Underwriting Agreement by and between Liquidia Corporation and BofA Securities, Inc., as representative of the underwriters named therein, dated December 12, 2023 (Liquidia Corp, Filed With SEC on December 14, 2023)
Underwriting Agreement, dated December 13, 2023, by and among Ocular Therapeutix, Inc. and Jefferies LLC, BofA Securities, Inc. and Piper Sandler & Co., as representatives of the... (OCULAR THERAPEUTIX, INC, Filed With SEC on December 14, 2023)
Underwriting Agreement, dated December 6, 2023, by and between the Company and J.P. Morgan Securities LLC and Leerink Partners LLC (Wave Life Sciences Ltd., Filed With SEC on December 8, 2023)
Underwriting Agreement, dated December 4, 2023, by and between EyePoint Pharmaceuticals, Inc. and J.P. Morgan Securities LLC (EyePoint Pharmaceuticals, Inc., Filed With SEC on December 8, 2023)
Underwriting Agreement, dated as of November 28, 2023, by and between Seelos Therapeutics, Inc. and Titan Partners Group, LLC (APRICUS BIOSCIENCES, INC., Filed With SEC on November 30, 2023)
Underwriting Agreement, dated October 30, 2023, by and among Bristol-Myers Squibb Company and the underwriters named therein (Bristol-Myers Squibb, Filed With SEC on November 13, 2023)
Underwriting Agreement, dated as of October 2, 2023, by and between the Company and J.P. Morgan Securities LLC, as representative of the several underwriters (Biohaven Ltd., Filed With SEC on October 5, 2023)
Underwriting Agreement, dated September 11, 2023 (CymaBay Therapeutics, Inc., Filed With SEC on September 12, 2023)
Underwriting Agreement, dated as of August 24, 2023, by and between Societal CDMO, Inc. and Craig-Hallum Capital Group, LLC, as representative of the underwriters (Recro Pharma, Inc., Filed With SEC on August 28, 2023)
Form of Underwriting Agreement (Cingulate Inc., Filed With SEC on August 22, 2023)
Underwriting Agreement, between the Company, Cowen and Company, LLC, Leerink Partners LLC and Evercore Group L.L.C., dated as of August 15, 2023 (AN2 Therapeutics, Inc., Filed With SEC on August 16, 2023)
Underwriting Agreement dated as of August 14, 2023 between the Company and The Benchmark Company, LLC (TFF Pharmaceuticals, Inc., Filed With SEC on August 15, 2023)
Underwriting Agreement, dated as of August 2, 2023, by and among the Company, Kingswood Investments, division of Kingswood Capital Partners, LLC and the other underwriters named... (MIRA PHARMACEUTICALS, INC., Filed With SEC on August 7, 2023)
Underwriting Agreement, dated August 1, 2023, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc. and Guggenheim Securities, LLC (Tarsus Pharmaceuticals, Inc., Filed With SEC on August 2, 2023)
Underwriting Agreement between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein, dated July 18, 2023 (HARROW HEALTH, INC., Filed With SEC on July 21, 2023)
Form of Underwriting Agreement (MIRA PHARMACEUTICALS, INC., Filed With SEC on July 18, 2023)
Underwriting Agreement dated as of July 12, 2023, by and between the Company and WallachBeth Capital LLC (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on July 17, 2023)